PATENT CLAIM ANALYSIS

Application Number: 15744345
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["424", "130100"]

Abstract:
The present invention relates to the field of muscle regeneration, and more particularly to the replenishment of the in vivo muscle stem cells pool. It more specifically relates to a 5-hydroxytryptamine B1 receptor-stimulating agent, and to a composition comprising said agent, for use as i) a promoter of satellite cells self-renewal and/or differentiation, and/or ii) an agent preventing and/or inhibiting the satellite cells pool exhaustion. The invention further encompasses therapeutic and screening methods.

Claim (Index 17):
In vitro use of a 5-hydroxytryptamine 1B receptor (5-HT1 BR)-stimulating agent as defined in any one of  claims 1  to  11 , for promoting satellite cells self-renewal and/or differentiation.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 86.0
- Lexical Diversity: 1.60784
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15241523', '09936609', '11246282', '12099054', '13206913']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6666017086839812
- 35 USC 102 Novelty (BERT): 0.504130011004266
- Combined Prediction Score: 0.6503545389160096
- Mean Citation Score: 190.404522
- Max Citation Score: 207.48035
- Similarity Product: 127.3202846436262

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test